The Effectiveness of Shared Decision-making for Diabetes Prevention: 24- and 36-Month Results From the Prediabetes Informed Decision and Education (PRIDE) Trial.
Journal Information
Full Title: Diabetes Care
Abbreviation: Diabetes Care
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Duality of Interest. No potential conflicts of interest relevant to this article were reported."
"This study was funded by the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (R18DK105464). T.M. also receives support from the Department of Veterans Affairs (QUE15-272, QUE15-286, and CSP2002). C.M.M. and O.K.D. receive support from the University of California at Los Angeles (UCLA), Resource Centers for Minority Aging Research Center for Health Improvement of Minority Elderly (RCMAR/CHIME) under NIH, National Institute on Aging grant P30-AG021684. C.M.M. receives support from NIH, National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute grant UL1TR000124 and holds the Barbara A. Levey and Gerald S. Levey Endowed Chair in Medicine, which partially supported her work. O.K.D. is supported in part by the NIH National Institute on Aging Career Development."
"The PRIDE study design has been described elsewhere (). In brief, we included patients between 18 and 74 years with overweight/obesity and prediabetes. We excluded patients with diabetes, chronic kidney disease stage 4 or higher, active eating disorder(s), or who were pregnant or planning to become pregnant in the next year. Eligible patients in intervention practices received a study invitation letter signed by their primary care provider. The study was approved by the University of California, Los Angeles Institutional Review Board (IRB no. 15-000310) and was registered at ClinicalTrials.gov (NCT02384109)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025